BFSG LLC’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.62M | Sell |
35,943
-391
| -1% | -$45.8K | 0.41% | 73 |
|
|
2026
Q1 | $4.37M | Sell |
36,334
-1,465
| -4% | -$169K | 0.41% | 77 |
|
|
2025
Q4 | $3.98M | Sell |
37,799
-1,660
| -4% | -$156K | 0.39% | 84 |
|
|
2025
Q3 | $3.31M | Buy |
39,459
+2,867
| +8% | +$236K | 0.32% | 101 |
|
|
2025
Q2 | $2.9M | Buy |
36,592
+2,407
| +7% | +$191K | 0.32% | 99 |
|
|
2025
Q1 | $3.07M | Buy |
34,185
+1,294
| +4% | +$121K | 0.37% | 94 |
|
|
2024
Q4 | $3.27M | Buy |
32,891
+1,129
| +4% | +$116K | 0.38% | 89 |
|
|
2024
Q3 | $3.61M | Buy |
31,762
+923
| +3% | +$110K | 0.42% | 80 |
|
|
2024
Q2 | $3.82M | Buy |
30,839
+435
| +1% | +$56K | 0.48% | 74 |
|
|
2024
Q1 | $4.01M | Sell |
30,404
-54
| -0.2% | -$6.66K | 0.53% | 67 |
|
|
2023
Q4 | $3.32M | Sell |
30,458
-580
| -2% | -$60.2K | 0.48% | 75 |
|
|
2023
Q3 | $3.19M | Sell |
31,038
-125
| -0.4% | -$13.5K | 0.52% | 71 |
|
|
2023
Q2 | $3.6M | Buy |
31,163
+2,059
| +7% | +$234K | 0.61% | 57 |
|
|
2023
Q1 | $3.1M | Buy |
29,104
+179
| +0.6% | +$19.3K | 0.57% | 65 |
|
|
2022
Q4 | $3.21M | Buy |
28,925
+1,082
| +4% | +$111K | 0.64% | 55 |
|
|
2022
Q3 | $2.4M | Sell |
27,843
-191
| -0.7% | -$17.1K | 0.51% | 70 |
|
|
2022
Q2 | $2.56M | Sell |
28,034
-435
| -2% | -$38.6K | 0.46% | 76 |
|
|
2022
Q1 | $2.34M | Sell |
28,469
-855
| -3% | -$67.4K | 0.37% | 80 |
|
|
2021
Q4 | $2.25M | Sell |
29,324
-235
| -0.8% | -$18.7K | 0.31% | 98 |
|
|
2021
Q3 | $2.22M | Sell |
29,559
-270
| -0.9% | -$20.5K | 0.34% | 92 |
|
|
2021
Q2 | $2.32M | Sell |
29,829
-4,573
| -13% | -$340K | 0.42% | 86 |
|
|
2021
Q1 | $2.53M | Sell |
34,402
-2,765
| -7% | -$204K | 0.41% | 78 |
|
|
2020
Q4 | $2.9M | Buy |
37,167
+157
| +0.4% | +$12K | 0.48% | 66 |
|
|
2020
Q3 | $2.93M | Buy |
37,010
+63
| +0.2% | +$4.93K | 0.55% | 58 |
|
|
2020
Q2 | $2.73M | Sell |
36,947
-120
| -0.3% | -$9.03K | 0.59% | 56 |
|
|
2020
Q1 | $2.72M | Buy |
37,067
+68
| +0.2% | +$5.34K | 0.7% | 49 |
|
|
2019
Q4 | $3.21M | Sell |
36,999
-497
| -1% | -$40.8K | 0.61% | 55 |
|
|
2019
Q3 | $3M | Buy |
37,496
+2,991
| +9% | +$240K | 0.67% | 48 |
|
|
2019
Q2 | $2.76M | Sell |
34,505
-544
| -2% | -$41.7K | 1.08% | 27 |
|
|
2019
Q1 | $2.78M | Sell |
35,049
-79
| -0.2% | -$5.91K | 1.04% | 29 |
|
|
2018
Q4 | $2.56M | Buy |
35,128
+172
| +0.5% | +$12.1K | 1.16% | 27 |
|
|
2018
Q3 | $2.37M | Sell |
34,956
-760
| -2% | -$48.4K | 1% | 37 |
|
|
2018
Q2 | $2.07M | Buy |
35,716
+311
| +0.9% | +$17.5K | 0.91% | 41 |
|
|
2018
Q1 | $1.84M | Sell |
35,405
-309
| -0.9% | -$16.7K | 0.82% | 46 |
|
|
2017
Q4 | $1.92M | Buy |
35,714
+451
| +1% | +$25K | 0.81% | 47 |
|
|
2017
Q3 | $2.15M | Sell |
35,263
-1,815
| -5% | -$110K | 0.97% | 36 |
|
|
2017
Q2 | $2.27M | Buy |
37,078
+1,300
| +4% | +$79.1K | 1.11% | 30 |
|
|
2017
Q1 | $2.17M | Buy |
+35,778
| New | +$2.17M | 1.09% | 33 |
|
Other funds holding MRK
ECSS
BFSG LLC's MRK Position: Q2 2026 in Review
BFSG LLC reduced its Merck (MRK) stake by 1.1% in Q2 2026, selling an estimated $45.8K and leaving 35,943 shares worth $4.62M. The position accounts for 0.41% of the portfolio, ranked #73.
BFSG LLC first reported a position in MRK in Q1 2017 and has held it in 38 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- BFSG LLC held 35,943 shares of Merck worth $4.62M as of Q2 2026.
- BFSG LLC sold 391 Merck shares in Q2 2026, an estimated $45.8K.
- Merck made up 0.41% of BFSG LLC's portfolio in Q2 2026, its #73 holding.
- BFSG LLC first reported a position in Merck in Q1 2017 and has held it in 38 quarters since.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.